NCT03090815View on ClinicalTrials.gov

Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Adenocarcinoma of Lung (Disorder)
Interventions
GENETIC

Sequencing of ctDNA in plasma

Sequencing of ctDNA in plasma

Trial Locations (1)

0

RECRUITING

University of Hong Kong Queen Mary Hospital, Hong Kong

Sponsors
All Listed Sponsors
collaborator

Feinstein Institute for Medical Research

OTHER

lead

The University of Hong Kong

OTHER